At a glance
ClinicalIndex Comparison RecordN/ACompleted· 543 enrolled
Drug / intervention
voriconazole tabletdrug
Likely dose
voriconazole tablet 200 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet
In Brief
An observational study evaluating voriconazole tablet for Serious Fungal Infections. Completed, enrolled 543 participants.
Detailed Summary
This is a non-interventional study of voriconazole tablet in Korea which is mandated by the Korean government agency.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSerious Fungal Infections
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2006
Primary CompletionOct 2009
First PostedFeb 2010
TodayJul 2026
First PostedFeb 23, 2010
Enrollment StartMar 1, 2006
Primary CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 16.4 years ago
Interventions
voriconazole tabletdrug
200 mg PO bid (orally, twice a day)